
               
               
               CLINICAL PHARMACOLOGY
               
                  
The parent compound is a prodrug, which undergoes hepatic biotransformation to the active component, 6- methoxy-2-naphthylacetic acid (6MNA), that is a potent inhibitor of prostaglandin synthesis.

                  
                  

                  
It is acidic and has an n-octanol:phosphate buffer partition coefficient of 0.5 at pH 7.4.

                  

               
               
               
                  
                     MM2
                     
                        
                     
                  
               
            
         